FDA Inspection
Delta Pharma, Inc.Delta Pharma, Inc. – FDA Inspection, May 20, 2022
Record Details
This FDA Inspection record concerns Delta Pharma, Inc., with an inspection on May 20, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Delta Pharma, Inc.
- Inspection Date
- May 20, 2022
- Product Type
- Drugs
View Company Profile
ID · 79d66fe7-f3d0-4dd0-9136-9d0c83bd51c0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1169898
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.42(c)(10)Aseptic Processing Area
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delta Pharma, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | New Orleans District Office | Drug Quality Assurance |
| April 12, 2024 | Not classified | New Orleans District Office | Drug Quality Assurance |
| June 2, 2023 | VAI | New Orleans District Office | |
| February 23, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Delta Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.